NeuroThera Labs, in collaboration with Clearmind Medicine, has expanded its U.S. patent portfolio with three new applications covering combinations of LSD, ketamine, and ibogaine with its proprietary PEA technology. These patents aim to support treatments for mental health issues like depression and PTSD, as well as substance use and pain disorders. This builds on previous patents involving MDMA and PEA, highlighting NeuroThera's focus on innovative therapies using psychedelic compounds. The companies continue to develop safer, effective treatments for growing mental health needs while strengthening their intellectual property.
NeuroThera Labs patent expansion news provides context for health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Sep 23, 2026 18:02 WIB: Of 100 priced US health stocks, 55 rose and 37 fell. Humana Inc (HUM) closed at USD 378.73, up 1.83%, with 81% sell orders on Pluang. BridgeBio Pharma Inc (BBIO) rose 1.75% to USD 70.44, with 100% buy orders. Mesoblast Limited (MESO) fell 1.70% to USD 15.65, with a typical hold time of 12 days.
XRP Ledger developers have proposed an update to their LendingProtocolV1_2 to correct how loan repayments are rounded. The change aims to prevent small rounding differences from accumulating and causing the final loan installment to exceed the schedu...
Coinbase plans to open spot trading for the Collector Crypt token (ticker CARD) against the U.S. dollar, but only if liquidity conditions are satisfied. The trading will be limited to supported regions, and the exact launch date remains undecided. Pr...
Kimberly-Clark has completed its merger with Kenvue despite facing challenges in 2026. The merger is expected to generate $1.9 billion in synergies by 2029, supporting long-term earnings per share growth of around 6% and enabling continued dividend i...
Binance, the world's largest crypto exchange, has resumed withdrawals for Hyperliquid's HYPE token following a $6.4 billion hack linked to a North Korean group. The reopening came after a thorough audit and a week-long delay that caused community bac...
Coinbase will suspend trading, deposits, and withdrawals of native ZetaChain (ZETACHAIN) tokens from December 7 to 10 to migrate to Ethereum-based ZetaChain (ZETA). As of November 7, ZETACHAIN trading was limited to limit-only orders. Users holding Z...
